India Resurgence Fund, promoted by Piramal Enterprises and Bain Capital Credit, has invested ₹992 crore in drug firm Panacea Biotec..This investment is structured by way of non-convertible debentures (NCDs) of up to ₹864 crore and subscription amount of ₹32 crore towards share warrants to be allotted on a preferential basis, reported Mint..Trilegal and Ropes & Gray acted for the investors..TrilegalPartnerCounselAssociatesCorporate Nishant Parikh, Anirudh Agarwala, Arjun Ghose, Kunaal Shah Sneha Vardhan, Tejas AdigaSenior Associates: Anshul Gosavi, Samira Lalani, Aakriti Shakdher, Sneha Agnihotri, Deep Choudhuri, Rahil PereiraAssociates: Kartik Adhlakha, Snigdha Guha Roy, Srirang Sapre, Deepan Shah, Payal Desai, Ritwik Dash, Akshaya Venkataraman, Gazzal Bishnoi, Vaibhavi Shaunak, Maitreya Shaunak, Nayan Jain, Vruiti Patel, Vaishali Movva.Shardul Amarchand Mangaldas & Co advised Panacea Biotec.Sam & CoPartnerAssociatesCorporateAbhinav BhalaikPrincipal Associate: Daryush Marfatia, Senior Associates: Neekesh Shetty, Gaurav Dugar, Associates: Chirag Shah, Purva Phadke, Tanay Khanna, Harshvardhan Sunder and Gauri Pathak.Due DiligenceAbhinav Bhalaik Mukul BavejaSenior Associates:Asmita Kerkar, Neekesh ShettyAssociates: TanveeVasudevan, Devika Menon, Avni Merchant, Purva Phadke, Shradha NigamBanking & FinanceSapan Gupta Soummo BiswasSenior Associate: G. Meenakshi Associate: Swati Lal.Khaitan & Co acted for one of the promoters of the company..Bar & Bench is available on WhatsApp. For real-time updates on stories, click here to subscribe to our WhatsApp.
